Measures introduced to protect employees and to reduce risk of any potential contagion
According to draft resolutions for general meeting
Endorses spending of Vraylar cash
For treatment of uterine fibroids and endometriosis
Including Richter, OTP, Mol
Results of Portfolio's monthly poll are here
Company signs exclusive license and supply agreement
To be sold in Europe and Russia
Management considered overly conservative
Double-digit increase possible in U.S. and Western Europe
Fourth-quarter revenue rises to new record high
Analysts estimate 10% y/y increase
Recommendation remains 'Accumulate'
Almsot half a million shares
Annual BUX forecasts now more pessimistic
Lock-up period expires
Stock of own shares nears 1 mn
Richter product launched in Japan by partner
OTP also sets new record price
Mol, OTP ride the bull